Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series.


Journal

Journal of addictive diseases
ISSN: 1545-0848
Titre abrégé: J Addict Dis
Pays: England
ID NLM: 9107051

Informations de publication

Date de publication:
Historique:
pubmed: 25 3 2020
medline: 30 7 2021
entrez: 25 3 2020
Statut: ppublish

Résumé

Opioid addiction, if not well diagnosed and treated, can be a significant challenge for optimal pain management even in cancer patients. To date there is no definitive pharmacological standard of care for treating addiction, especially in this setting of patients. We present a clinical case series of three opioid-addicted advanced cancer patients, effectively treated with haloperidol, a well-known first-generation typical antipsychotic.

Identifiants

pubmed: 32207385
doi: 10.1080/10550887.2020.1742560
doi:

Substances chimiques

Dopamine Antagonists 0
Haloperidol J6292F8L3D

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

229-234

Auteurs

Alessandro Parisi (A)

Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Maria Vittoria Pensieri (MV)

Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Alessio Cortellini (A)

Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Carla D'Orazio (C)

Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Corrado Ficorella (C)

Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Lucilla Verna (L)

Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Giampiero Porzio (G)

Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH